Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Vestergaard

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
Acta Dermato-Venereologica|July 19, 2025
Alopecia Areata: Impact on Patients' Quality of Life and Disease Perception: A Survey-Based StudyChristian Vestergaard, Daniel de la Rosa Carrillo, Randeep Mandla, et al.
Clinical and Translational Allergy|February 14, 2024
A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown-CSU studyMurat Türk, Emek Kocatürk, Ragıp Ertaş, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 13, 2020
Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobiaTrine Gerner, Jeanette Halskou Haugaard, Christian Vestergaard, et al.
Dermatology (Basel, Switzerland)|November 5, 2023
Smartphone Photographs of Chronic Urticaria Taken by Patients Are of Good Quality and Useful in the ClinicZarqa Ali, Jennifer Astrup Sørensen, Ditte Georgina Zhang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 13, 2025
Omalizumab dosing patterns and drug survival in adult patients with chronic spontaneous urticariaDitte Georgina Zhang, Mia-Louise Nielsen, Jennifer Astrup Sørensen, et al.
The British Journal of Dermatology|June 26, 2024
Urticaria and the risk of cancer: a Danish population-based cohort studySissel B T Sørensen, Dóra K Farkas, Christian Vestergaard, et al.
JAMA Dermatology|April 8, 2026
Atopic Dermatitis and Academic PerformanceRita J Iskandar, Aurélie Mailhac, Amy Mulick, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 18, 2025
National and Regional Drug Survival of Omalizumab in Chronic Spontaneous Urticaria: A Danish Cohort StudyDitte Georgina Zhang, Mia-Louise Nielsen, Christian Vestergaard, et al.
The Journal of Dermatological Treatment|March 12, 2026
Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 yearsEric Simpson, Tilo Biedermann, Leon Kircik, et al.
Dermatology and Therapy|May 22, 2024
Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe ItchJosé-Manuel Carrascosa, Alessandra Narcisi, Toshifumi Nomura, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Acta Dermato-Venereologica|July 19, 2025
Alopecia Areata: Impact on Patients' Quality of Life and Disease Perception: A Survey-Based StudyChristian Vestergaard, Daniel de la Rosa Carrillo, Randeep Mandla, et al.
Clinical and Translational Allergy|February 14, 2024
A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown-CSU studyMurat Türk, Emek Kocatürk, Ragıp Ertaş, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 13, 2020
Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobiaTrine Gerner, Jeanette Halskou Haugaard, Christian Vestergaard, et al.
Dermatology (Basel, Switzerland)|November 5, 2023
Smartphone Photographs of Chronic Urticaria Taken by Patients Are of Good Quality and Useful in the ClinicZarqa Ali, Jennifer Astrup Sørensen, Ditte Georgina Zhang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 13, 2025
Omalizumab dosing patterns and drug survival in adult patients with chronic spontaneous urticariaDitte Georgina Zhang, Mia-Louise Nielsen, Jennifer Astrup Sørensen, et al.
The British Journal of Dermatology|June 26, 2024
Urticaria and the risk of cancer: a Danish population-based cohort studySissel B T Sørensen, Dóra K Farkas, Christian Vestergaard, et al.
JAMA Dermatology|April 8, 2026
Atopic Dermatitis and Academic PerformanceRita J Iskandar, Aurélie Mailhac, Amy Mulick, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 18, 2025
National and Regional Drug Survival of Omalizumab in Chronic Spontaneous Urticaria: A Danish Cohort StudyDitte Georgina Zhang, Mia-Louise Nielsen, Christian Vestergaard, et al.
The Journal of Dermatological Treatment|March 12, 2026
Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 yearsEric Simpson, Tilo Biedermann, Leon Kircik, et al.
Dermatology and Therapy|May 22, 2024
Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe ItchJosé-Manuel Carrascosa, Alessandra Narcisi, Toshifumi Nomura, et al.
Pageof 16